Optimi Health Corp.
Optimi Health is an end-to-end Canadian-based drug manufacturer and formulator licensed by Health Canada to produce and supply natural, GMP-grade psilocybin and synthetic psychedelic substances, as well as functional mushrooms that focus on the health and wellness markets. Built with the purpose of manufacturing pre-clinical to commercial scale Active Pharmaceutical Ingredients and finished product, the Issuer’s two GMP facilities in Princeton, British Columbia have fully integrated quality management systems in place, which include regular facility audits and external qualifications of all raw material and component suppliers to ensure the highest level of compliance. The Issuer’s goal is to be the number one trusted, compassionate supplier of safe drug products throughout the world.
Optimi Health Corp. (OPTI)
Communiqués de presse
le 22 février/February 2023
Optimi Health Corp. 24FEB2023 Warrants listed on February 25, 2021 will expire on February 24, 2023.
Settlement Terms: All trades February 22 and 23 will settle for cash next day. Trades on February 24, 2023 will be for cash same day.
The warrants will be halted at noon and delisted at market close February 24, 2023.